<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04163484</url>
  </required_header>
  <id_info>
    <org_study_id>11/2019</org_study_id>
    <nct_id>NCT04163484</nct_id>
  </id_info>
  <brief_title>Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease</brief_title>
  <official_title>Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>I.M. Sechenov First Moscow State Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>I.M. Sechenov First Moscow State Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to assess the prevalence of contrast-associated acute kidney injury
      in patients with stable coronary artery disease, ST-elevation myocardial infarction and
      unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury
      development and the influence of contrast-induced kidney injury on 1-year prognosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Contrast associated acute kidney injury</measure>
    <time_frame>48-72 hours</time_frame>
    <description>Number of patients with contrast associated kidney injury after contrast exposure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall mortality</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1 year</time_frame>
    <description>Number of patients with myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>PCI or CABG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat hospitalisation</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute decompensation of heart failure</measure>
    <time_frame>1 year</time_frame>
    <description>Number of patients with acute decompensation of heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic kidney disease progression</measure>
    <time_frame>1 year</time_frame>
    <description>Progression of chronic kidney disease in patients with decreased glomerular filtration rate on inclusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New-onset dialysis</measure>
    <time_frame>1 year</time_frame>
    <description>Number of patients with new-onset dialysis</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Angina, Unstable</condition>
  <condition>Angina, Stable</condition>
  <condition>STEMI - ST Elevation Myocardial Infarction</condition>
  <condition>NSTEMI - Non-ST Segment Elevation MI</condition>
  <condition>Contrast-induced Nephropathy</condition>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Stable coronary artery disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ST-elevation myocardial infarction</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ST-elevation myocardial infarction</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Iodinated contrast</intervention_name>
    <description>Intra-arterial injection of iodinated contrast media during percutaneous coronary intervention</description>
    <arm_group_label>Non-ST-elevation myocardial infarction</arm_group_label>
    <arm_group_label>ST-elevation myocardial infarction</arm_group_label>
    <arm_group_label>Stable coronary artery disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Males and females aged 18-80, who have the indication for treatment of CAD with PCI
        requiring the intra-arterial injection of iodinated contrast-media
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females aged 18-80

          -  Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI

          -  Intra-arterial injection of iodinated contrast media

          -  Informed consent

        Exclusion Criteria:

          -  Age less than 18

          -  Pregnancy, lactation

          -  Refuse to sign the informed consent

          -  Contraindications for PCI

          -  Other conditions affecting prognosis (oncology, liver failure etc)

          -  CKD stage 4-5

          -  Patients receiving nephrotoxic drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Olga Mironova, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>I. M. Sechenov First Moscow State Medical University (Sechenov University)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pauline Lakotka, MD</last_name>
    <phone>+79852175748</phone>
    <email>lakotkapolly@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sechenov University</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline Lakotka, MD</last_name>
      <email>lakotkapolly@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>November 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2019</study_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>I.M. Sechenov First Moscow State Medical University</investigator_affiliation>
    <investigator_full_name>Olga Mironova</investigator_full_name>
    <investigator_title>MD PhD Associate Professor</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>iodinated contrast media</keyword>
  <keyword>stable angina</keyword>
  <keyword>unstable angina</keyword>
  <keyword>STEMI</keyword>
  <keyword>NSTEMI</keyword>
  <keyword>PCI</keyword>
  <keyword>acute kidney injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

